Navigation Links
Late-stage ovarian cancer shows promise in two-drug phase I trial
Date:6/9/2010

INDIANAPOLIS -- The combination of decitabine and carboplatin appears to improve the outcome of women who have late-stage ovarian cancer. In an upcoming issue of the journal Cancer (online today), Indiana University researchers report four of 10 patients who participated in a phase I clinical trial had no disease progression after six months of treatment. One patient experienced complete resolution of tumor tissue for a period of time.

Advanced ovarian cancer is often diagnosed too late for treatment to be effective. Patients are often told they have virtually no chance of recovery and only months to live.

Women participating in the study were between 51 and 71, and had previously exhausted all approved treatments for ovarian cancer. They enrolled in an Indiana University Melvin and Bren Simon Cancer Center clinical trial designed to increase their sensitivity to the commonly prescribed ovarian cancer drug, platinum-based carboplatin.

Women with ovarian cancer usually survive less than one year after they become resistant to carboplatin and their cancer recurs, said co-principal investigator Daniela Matei, M.D., an associate professor of medicine at the Indiana University School of Medicine. Matei led the clinical portion of the trial.

"Carboplatin is the most efficient drug therapy for ovarian cancer," Matei said. "Unfortunately, patients with recurrent disease become resistant to the drug after one or two rounds."

Decitabine was first used to treat the study patients intravenously daily for five days followed on the eighth day with carboplatin. After a month, the regimen begins again.

Six months after the trial began, four of the patients had no disease progression. At eight-and-a-half months, seven patients were alive (and at press time, still alive). Cancerous tissue in one of the patients shrank completely.

Adverse reactions to the treatment regiments were mild, including nausea, fatigu
'/>"/>

Contact: Mary L. Hardin
mhardin@iupui.edu
317-274-7722
Indiana University School of Medicine
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Late-stage melanoma results in economic burden
2. Cancer Drug Safe for Late-Stage Pelvic Disease
3. Study Finds Possible Explanation for the Link Between Infertility and Breast/Ovarian Cancer Risks
4. Symptoms have little value for early detection of ovarian cancer
5. Symptoms Alone Dont Spot Ovarian Cancer Early
6. Ultrasound plus proteomic blood analyses may help physicians diagnose early-stage ovarian cancer
7. Abbott Receives European Regulatory Approval for New Ovarian Cancer Diagnostic Test
8. Possible ovarian cancer treatment target identified
9. Arrayit Diagnostics to Bring First Pre-Symptomatic Ovarian Cancer Blood Test to Multi-Billion Dollar Diagnostic Market in 2010
10. Research suggests link between infertility, low egg reserve, and breast/ovarian cancer gene (BRCA1)
11. How to make the best decisions when at high risk for breast or ovarian cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... Top medical tourism firm, VisitandCare.com, is ... ongoing commitment to providing superior patient experiences. Ojas ... with the best possible experience for a comprehensive range ... , Executives at Ojas Aesthetic Clinic persistently assert that, ... nothing about you, without you — through transparent engagement ...
(Date:4/21/2015)... Angelo’s FabriClean has recently announced that the company ... avail the area rug cleaning services. Area rug cleaning ... equipments, making use of the quick drying technique to ... pressure steam extraction to clean even the most stubborn ... made with delicate fabric. , “Good maintenance and ...
(Date:4/21/2015)... Somerset, NJ & New York, NY (PRWEB) April ... the leading global provider of advanced delivery technologies ... health products, today announced the launch of ADVASEPT™ ... the safe and efficient delivery of injectable medications. ... syringe, combining a safe, convenient and functional container ...
(Date:4/21/2015)... (PRWEB) April 21, 2015 QuickMedical, ... equipment and supplies, now represents Schiller America's ... Monitors, ECGs, Stress Tests, and Vital Signs Monitors, ... in Switzerland, is a global leader in the ... products are developed in close cooperation with the ...
(Date:4/21/2015)... Dallas, Texas (PRWEB) April 21, 2015 ... Global Sodium Citrate Industry is a professional and ... global Sodium Citrate Market with a ... companies included in the sodium citrate market research ... Acid Chemicals, Natural Biological, Cofco Biochemical, Capchem, Lianyungang ...
Breaking Medicine News(10 mins):Health News:VisitandCare.com Cosmetic Surgery Provider in India Earns Recognition for Patient Satisfaction 2Health News:VisitandCare.com Cosmetic Surgery Provider in India Earns Recognition for Patient Satisfaction 3Health News:Angelo’s FabriClean Now Offers Area Rug Cleaning in South Surrey with Complimentary Pick-Up and Delivery 2Health News:Catalent Announces the Expansion of its Advanced, Aseptic, Glass-Free Injectable Platform with New ADVASEPT™ Lock Delivery Technology 2Health News:QuickMedical Launches New Product Line: Schiller America 2Health News:QuickMedical Launches New Product Line: Schiller America 3Health News:Sodium Citrate Industry Global Key Manufacturers Analysis Report 2015-2020 2Health News:Sodium Citrate Industry Global Key Manufacturers Analysis Report 2015-2020 3
... phase of the illness, study says , , WEDNESDAY, Sept. 12 ... the manic phase of bipolar disorder, and works faster than ... a new study has found. , "One of the problems ... have this long period before they start to work," explained ...
... Chance to Help Make a Difference & Join ... N.C., Sept. 12 This fall, Pink is the color,of ... its,14th anniversary in the battle against Breast Cancer September 20 ... to save lives by,purchasing a new 25% Pink Savings Card. ...
... CDH plans continue to grow in popularity among ... Employees who fear high,out-of-pocket costs aren,t blocking the ... and employers take advantage of,money-saving options as healthcare ... Consulting Worldwide, the global human capital consulting,organization of ...
... prevailing issue in the United States, with millions of ... that Pycnogenol, (pic-noj-en-all), an antioxidant plant extract from the ... in children. The study shows Pycnogenol balances stress hormones, ... of ADHD. , The findings, to be published ...
... the days of Hippocrates, people have known that certain ... researchers have learned that these cyclic recurrences of disease, ... In order to accurately predict when outbreaks of disease ... Elena Naumova, PhD, associate professor in the Department of ...
... LOS GATOS, Calif., Sept. 12 Death may be the ... about. It is usually looked,upon as something to fear -- ... Darlyne intend to tear down the walls. "Triumph" is ... Philip,and Darlyne clarified and expressed their feelings about Darlyne,s,impending death ...
Cached Medicine News:Health News:Tamoxifen Helps Treat Bipolar Disorder 2Health News:Tamoxifen Helps Treat Bipolar Disorder 3Health News:Photo: Tanger Outlet Center Shoppers Nationwide can Choose Pink to Fight Breast Cancer 2Health News:National Survey Shows Employee Fears About Consumer-Driven Health Plans on Decline 2Health News:National Survey Shows Employee Fears About Consumer-Driven Health Plans on Decline 3Health News:National Survey Shows Employee Fears About Consumer-Driven Health Plans on Decline 4Health News:National Survey Shows Employee Fears About Consumer-Driven Health Plans on Decline 5Health News:National Survey Shows Employee Fears About Consumer-Driven Health Plans on Decline 6Health News:National Survey Shows Employee Fears About Consumer-Driven Health Plans on Decline 7Health News:National Survey Shows Employee Fears About Consumer-Driven Health Plans on Decline 8Health News:New study: Pine bark extract reduces ADHD symptoms in children 2Health News:Mathematics might save you a trip to the ER 2Health News:'Triumph' -- Traveling Towards Death: Preparing for a New Life 2
(Date:4/21/2015)... NEW YORK , April 21, 2015 ... Summary Sepsis is a life-threatening complication arising ... to the infection damages its own tissues and organs. ... common among children <1 year of age, ... Clinic, 2014). Global estimates for the year 2013 showed ...
(Date:4/21/2015)... SAN DIEGO , 21. April 2015 ... Software für die quantitative Analyse des Hirnvolumens ... AG, einem weltweiten Pharmaunternehmen, bekannt geben zu ... des leistungsstarken NeuroQuant-Quantifizierungsreports des Hirnvolumens zusammenarbeiten, der ... von Hirnvolumen in Patienten mit multipler Sklerose ...
(Date:4/21/2015)... InfuSystem Holdings, Inc. (NYSE MKT: INFU), a ... for the healthcare industry in the United ... announces today that it has closed the acquisition by ... Ciscura Holding Company, Inc., and its subsidiaries.  Ciscura, based ... privately-held Southeastern regional provider of ambulatory infusion pumps and ...
Breaking Medicine Technology:EpiCast Report: Sepsis - Epidemiology Forecast to 2023 2EpiCast Report: Sepsis - Epidemiology Forecast to 2023 3CorTechs Labs kündigt Partnerschaft für die Bereitstellung umfassender Lösungen zur Quantifizierung des Verlustes von Hirnvolumen bei multipler Sklerose an 2InfuSystem Announces Acquisition Of Ciscura's Infusion Pump Fleet 2InfuSystem Announces Acquisition Of Ciscura's Infusion Pump Fleet 3InfuSystem Announces Acquisition Of Ciscura's Infusion Pump Fleet 4
... Dec. 21, 2011  Ampio Pharmaceuticals, Inc. (Nasdaq: AMPE)("Ampio" or ... uses for previously approved drugs and new molecular entities ... agreements with accredited investors to sell an aggregate approximately ... $0.0001 per share (the "Shares"), at a price per ...
... Dec. 21, 2011 At a ceremony coinciding with ... Johnson,s public revelation that he had acquired HIV, the ... acknowledged Waters Corporation (NYSE: WAT ) for ... liquid chromatograph/mass spectrometer that will be used to build ...
Cached Medicine Technology:Ampio Pharmaceuticals Announces Registered Direct Common Stock Offering of Approximately $9.436 Million 2Ampio Pharmaceuticals Announces Registered Direct Common Stock Offering of Approximately $9.436 Million 3Waters Gifts Research Equipment to University at Buffalo to Combat HIV/AIDS 2Waters Gifts Research Equipment to University at Buffalo to Combat HIV/AIDS 3Waters Gifts Research Equipment to University at Buffalo to Combat HIV/AIDS 4
Chin Implants are used for cosmetic augmentation, repairing trauma related injuries and genetic deficiencies. They are inserted through an incision in the mouth below the incisor teeth or through an ...
... The IEC CL40 and FL40 Centrifuge ... safety and versatility to increase your ... a broad array of rotors and ... and microplate applications, the IEC CL40 ...
... CL40 and FL40 Centrifuge Series from ... versatility to increase your productivity in ... array of rotors and accessories for ... applications, the IEC CL40 and FL40 ...
... IEC CL31 Multispeed Series offers unsurpassed ... quiet, compact, 1.2 liter benchtop centrifuge. ... and accessories and high-speed centrifugation capabilities, ... everything you need to meet a ...
Medicine Products: